@gabriellevanram.bsky.social
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Wim Ceelen 🇧🇪 Ghent
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
October 15, 2025 at 2:03 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Wim Ceelen 🇧🇪 Ghent
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
Physically Enhanced IP Drug Delivery
Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. I discuss how physical methods overcome transport barriers.
Reposted
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Stefan Stättner 🇦🇹
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
October 15, 2025 at 2:55 PM
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Stefan Stättner 🇦🇹
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
Discussing Robotic Liver Surgery
Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems.
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Markus Mille 🇩🇪
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
October 15, 2025 at 3:10 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Markus Mille 🇩🇪
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
Discussing: Robotic Single Port SP Surgery
Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery
Reposted
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Oliver Gimm 🇸🇪
Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours
Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease.
Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours
Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease.
October 16, 2025 at 6:45 AM
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Oliver Gimm 🇸🇪
Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours
Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease.
Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours
Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease.
Reposted
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma to the Live
Examines the use of percutaneous hepatic perfusion for the treatment of metastatic uveal #melanoma to the liver
Examines the use of percutaneous hepatic perfusion for the treatment of metastatic uveal #melanoma to the liver
October 16, 2025 at 6:50 AM
Reposted
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
October 16, 2025 at 8:01 AM
Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy?
Reposted
Oncology Here & NOW S2E3 in #BreastCancer
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:
✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:
✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
Oncology Here and Now podcast (Breast Cancer) S02E03 w/ Dr. Erika Hamilton and Dr. Elisa Agostinetto
YouTube video by OncoAlert 360
youtu.be
October 6, 2025 at 2:06 PM
Oncology Here & NOW S2E3 in #BreastCancer
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:
✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:
✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
October 15, 2025 at 7:00 AM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
The Immune Microenvironment in Peritoneal Metastases
The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory, immune-regulated niche
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Anders Thornell 🇸🇪 Sahlgrenska
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
October 15, 2025 at 9:02 AM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Anders Thornell 🇸🇪 Sahlgrenska
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated?
Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and guideline evolution.
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
October 15, 2025 at 12:02 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
Presentation reviews current AJCC staging system for melanoma, outline present state of staging practices, and explore potential areas for refinement
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Laura Lorenzon 🇮🇹
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
October 15, 2025 at 12:20 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Laura Lorenzon 🇮🇹
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
Investigation and Management of GI Symptoms After Surgery
This presentation highlights the main dimensions related to quality of life, the main metrics used to measure symptoms and the main issues in this field
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Lasma Nikolaisone 🇱🇻
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
October 15, 2025 at 1:15 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Lasma Nikolaisone 🇱🇻
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
The Testimonial of a Young Rectal Cancer Patient
Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly #RectalCancer
Reposted
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Øyvind Bruland 🇳🇴 Oslo
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
October 15, 2025 at 1:45 PM
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Øyvind Bruland 🇳🇴 Oslo
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally
Today I was featured in a series on quiet leadership by Pia Cox on LinkedIn
#womeninsurgery #oncology #womeninmaledominatedfields #equityinleadership
#womeninsurgery #oncology #womeninmaledominatedfields #equityinleadership
August 26, 2025 at 8:22 PM
Today I was featured in a series on quiet leadership by Pia Cox on LinkedIn
#womeninsurgery #oncology #womeninmaledominatedfields #equityinleadership
#womeninsurgery #oncology #womeninmaledominatedfields #equityinleadership
Reposted
The Tripartite- one of the world’s leading colorectal conferences- in #Paris this year 🇫🇷
This pre-course led by Prof Gabrielle van Ramshorst is a chance for trainees to upgrade their presentation skills. And a trip to Paris - what’s not to love?! More ⬇️
escp.eu.com/conference-and…
This pre-course led by Prof Gabrielle van Ramshorst is a chance for trainees to upgrade their presentation skills. And a trip to Paris - what’s not to love?! More ⬇️
escp.eu.com/conference-and…
https://escp.eu.com/conference-and…
July 5, 2025 at 8:08 AM
The Tripartite- one of the world’s leading colorectal conferences- in #Paris this year 🇫🇷
This pre-course led by Prof Gabrielle van Ramshorst is a chance for trainees to upgrade their presentation skills. And a trip to Paris - what’s not to love?! More ⬇️
escp.eu.com/conference-and…
This pre-course led by Prof Gabrielle van Ramshorst is a chance for trainees to upgrade their presentation skills. And a trip to Paris - what’s not to love?! More ⬇️
escp.eu.com/conference-and…
How to improve our patient outcomes? Presenting #Wolverine #SSOSummit2025 and Ines Rubio speaking about increasing SSI awareness among surgeons in Spain
April 8, 2025 at 12:56 PM
How to improve our patient outcomes? Presenting #Wolverine #SSOSummit2025 and Ines Rubio speaking about increasing SSI awareness among surgeons in Spain
Heidi Nelson received the Charles M. Batch Distinguished Service Award #SSO2025 @socsurgonc.bsky.social
March 28, 2025 at 2:46 PM
Heidi Nelson received the Charles M. Batch Distinguished Service Award #SSO2025 @socsurgonc.bsky.social
James Ewing lecture by Susan Domchek #SSO2025 @socsurgonc.bsky.social
March 27, 2025 at 12:09 PM
James Ewing lecture by Susan Domchek #SSO2025 @socsurgonc.bsky.social
Reposted
It is perfectly legal to know your rights and to educate others about them, too.
EVERYONE in the United States, citizen or not, has rights. I will not allow this administration to intimidate us from helping you know about them.
Here’s our shareable guide ⬇️: (pt. 1/2)
EVERYONE in the United States, citizen or not, has rights. I will not allow this administration to intimidate us from helping you know about them.
Here’s our shareable guide ⬇️: (pt. 1/2)
February 14, 2025 at 11:47 PM
It is perfectly legal to know your rights and to educate others about them, too.
EVERYONE in the United States, citizen or not, has rights. I will not allow this administration to intimidate us from helping you know about them.
Here’s our shareable guide ⬇️: (pt. 1/2)
EVERYONE in the United States, citizen or not, has rights. I will not allow this administration to intimidate us from helping you know about them.
Here’s our shareable guide ⬇️: (pt. 1/2)
www.linkedin.com/posts/gabrie...
🎙️Catch Part 2 of the Fellows and Young Attendings Podcast: "Letters to My Younger Self" and hear from leaders about how they develop work-life balance in the field of surgical oncology.
Listen now on Spotify or at surgonc.org/education/su...
🎙️Catch Part 2 of the Fellows and Young Attendings Podcast: "Letters to My Younger Self" and hear from leaders about how they develop work-life balance in the field of surgical oncology.
Listen now on Spotify or at surgonc.org/education/su...
Gabrielle van Ramshorst on LinkedIn: Society of Surgical Oncology
🎙️Catch Part 2 of the Fellows and Young Attendings Podcast: "Letters to My Younger Self" and hear from leaders about how they develop work-life balance in the…
www.linkedin.com
February 15, 2025 at 5:34 PM
www.linkedin.com/posts/gabrie...
🎙️Catch Part 2 of the Fellows and Young Attendings Podcast: "Letters to My Younger Self" and hear from leaders about how they develop work-life balance in the field of surgical oncology.
Listen now on Spotify or at surgonc.org/education/su...
🎙️Catch Part 2 of the Fellows and Young Attendings Podcast: "Letters to My Younger Self" and hear from leaders about how they develop work-life balance in the field of surgical oncology.
Listen now on Spotify or at surgonc.org/education/su...
Reposted
Kickstart your #SSO2025 experience with a pre-course! These sessions offer an exceptional opportunity to dive deep into specialized topics, connect with experts, and gain knowledge to advance your practice. ow.ly/kz4I50UHLBo
January 23, 2025 at 6:33 PM
Kickstart your #SSO2025 experience with a pre-course! These sessions offer an exceptional opportunity to dive deep into specialized topics, connect with experts, and gain knowledge to advance your practice. ow.ly/kz4I50UHLBo